- Home
- IAE vs OPRX Comparison
IAE vs OPRX Comparison
Compare IAE & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IAE
Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | IAE | OPRX |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.0M | 117.1M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | IAE | OPRX |
|---|---|---|
| Price | $8.50 | $6.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 86.1K | ★ 301.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 10.21% | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $6.65 | $4.54 |
| 52 Week High | $9.27 | $22.25 |
Technical Indicators
Market Signals| Indicator | IAE | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 56.91 |
| Support Level | $8.43 | $6.03 |
| Resistance Level | $9.25 | $6.93 |
| Average True Range (ATR) | 0.19 | 0.24 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 32.15 | 48.47 |
Price Performance
Historical ComparisonAbout IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.